(Q37054156)

17 August 2017

1 reference

title

Surgical management of large renal tumors (English)

1 reference

17 August 2017

Matthew F Wszolek

1

1 reference

17 August 2017

Chad Wotkowicz

series ordinal

2

1 reference

17 August 2017

John A Libertino

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

published in

Nature Reviews Urology

1 reference

17 August 2017

volume

5

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

35-46

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0963

17 August 2017

exact match

0 references

cites work

Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Rising incidence of renal cell cancer in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Long-term outcomes of the surgical management of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

RENAL CELL CARCINOMA: PROGNOSTIC SIGNIFICANCE OF INCIDENTALLY DETECTED TUMORS

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Surgery for renal cell carcinoma extending into the inferior vena cava

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Preoperative imaging in renal cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Preoperative renal tumor evaluation by three-dimensional magnetic resonance imaging: Staging and detection of multifocality

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Treatment of renal cancer patients by transcatheter embolization and its effects on lymphocyte proliferative responses

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Renal artery embolization: clinical indications and experience from over 100 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

The results of radical nephrectomy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Renal cell carcinoma: vena caval involvement.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Management of renal cell carcinoma with vena cava and atrial thrombus: minimal access vs median sternotomy with circulatory arrest

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Laparoscopic radical nephrectomy for large (greater than 7 cm, T2) renal tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Laparoscopic radical nephrectomy: comparison of clinical Stage T1 and T2 renal tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Laparoscopic partial nephrectomy for incidental stage pT2 or worse tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Renal cell cancer: radical nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Advances in immune-based therapies of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0963

7 January 2021

Identifiers

DOI

10.1038/NCPURO0963

1 reference

17 August 2017

1 reference